Occurrence Rates and Risk Factors of Pancreatic Cancer
Pancreatic cancer has an age-standardized incidence rate of approximately 10-12 cases per 100,000 population in Western countries, with higher rates in men than women, and is associated with a dismal prognosis where mortality rates nearly equal incidence rates due to late diagnosis and poor treatment response. 1
Global Incidence and Mortality
Incidence Rates
- In Europe, pancreatic cancer is the 7th most frequent cancer, accounting for 2.8% of cancers in men and 3.2% in women 1
- Annual incidence rates in Europe:
- In the USA, the SEER program showed a decline in total incidence from 12.3 per 100,000 in 1973 to 10.7 per 100,000 in 1999 1
- Worldwide, over 458,918 new cases were reported in 2018 2
Mortality Rates
- Fifth leading cause of cancer-related death in Europe with approximately 70,000 deaths annually 1
- Predicted to become the fourth cause of cancer death in both sexes in the European Union 1
- Extremely high fatality rate with >95% of affected individuals dying of the disease 1
- Five-year survival rate remains at only 9% 2
Age and Gender Distribution
- Incidence increases steeply with age:
- 1.5 per 100,000/year in patients aged 15-44 years
- 55 per 100,000/year in patients >65 years of age 1
- 80% of cases occur in the 60-80 year age group 1
- Men have approximately 50% higher age-adjusted incidence rate than women 1
Anatomical Distribution
- 75% of ductal pancreatic carcinomas occur within the head or neck of the pancreas
- 15-20% in the body of the pancreas
- 5-10% in the tail of the pancreas 1
Major Risk Factors
Established Risk Factors
Cigarette smoking:
Chronic pancreatitis:
Diabetes mellitus:
Obesity and metabolic syndrome factors:
Genetic factors:
Other established risk factors:
Genetic Syndromes Associated with Increased Risk
- Hereditary pancreatitis syndrome
- Hereditary non-polyposis colorectal cancer (HNPCC)
- Hereditary atypical multiple mole melanoma syndrome
- Hereditary BRCA2-related breast and ovarian cancer
- Peutz-Jeghers syndrome
- Familial adenomatous polyposis (FAP) 1
Clinical Implications and Prevention
Screening
- No efficient screening tools available for general population 1
- Targeted screening recommended only for high-risk populations:
- Those with hereditary conditions
- Regular endoscopic ultrasound (EUS) and MRI recommended for high-risk individuals 1
Prevention Strategies
- Smoking cessation - risk reduction observed within a decade after quitting 6
- Maintaining healthy weight and physical activity 3, 5
- Consuming at least five servings of vegetables and fruits daily 3
- Avoiding heavy alcohol consumption 5
Clinical Presentation
- Often diagnosed late due to lack of early symptoms 1
- Common presenting symptoms:
- Jaundice (predominant in head of pancreas tumors)
- Abdominal or back pain (predominant in body and tail tumors)
- Weight loss
- New-onset diabetes (in up to 10% of patients) 1
Diagnostic Challenges
- Late diagnosis due to asymptomatic early disease and non-specific symptoms 1
- Difficult differentiation between focal chronic pancreatitis and pancreatic cancer 3
- Standard tumor markers like CA 19-9 may be normal in pancreatic cancer 3
The high mortality rate of pancreatic cancer underscores the importance of risk factor modification and targeted surveillance in high-risk populations, as early detection remains challenging and treatment options for advanced disease remain limited.